Literature DB >> 23846565

Susceptibility to CD8 T-cell-mediated killing influences the reservoir of latently HIV-1-infected CD4 T cells.

Maria J Buzon1, Yue Yang, Zhengyu Ouyang, Hong Sun, Katherine Seiss, Jerome Rogich, Sylvie Le Gall, Florencia Pereyra, Eric S Rosenberg, Xu G Yu, Mathias Lichterfeld.   

Abstract

BACKGROUND: HIV-1 establishes a lifelong infection in the human body, but host factors that influence viral persistence remain poorly understood. Cell-intrinsic characteristics of CD4 T cells, the main target cells for HIV-1, may affect the composition of the latent viral reservoir by altering the susceptibility to CD8 T-cell-mediated killing.
RESULTS: We observed that susceptibilities of CD4 T cells to CD8 T-cell-mediated killing, as determined in direct ex vivo assays, were significantly higher in persons with natural control of HIV-1 (elite controllers) than in individuals effectively treated with antiretroviral therapy. These differences were most pronounced in naive and in terminally differentiated CD4 T cells and corresponded to a reduced viral reservoir size in elite controllers. Interestingly, the highest susceptibility to CD8 T-cell-mediated killing and lowest reservoirs of cell-associated HIV-1 DNA was consistently observed in elite controllers expressing the protective HLA class I allele B57.
CONCLUSIONS: These data suggest that the functional responsiveness of host CD4 T cells to cytotoxic effects of HIV-1-specific CD8 T cells can contribute to shaping the structure and composition of the latently infected CD4 T-cell pool.

Entities:  

Mesh:

Year:  2014        PMID: 23846565      PMCID: PMC3874432          DOI: 10.1097/QAI.0b013e3182a1bc81

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  34 in total

1.  High-functional-avidity cytotoxic T lymphocyte responses to HLA-B-restricted Gag-derived epitopes associated with relative HIV control.

Authors:  Christoph T Berger; Nicole Frahm; David A Price; Beatriz Mothe; Musie Ghebremichael; Kari L Hartman; Leah M Henry; Jason M Brenchley; Laura E Ruff; Vanessa Venturi; Florencia Pereyra; John Sidney; Alessandro Sette; Daniel C Douek; Bruce D Walker; Daniel E Kaufmann; Christian Brander
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

Review 2.  The challenge of finding a cure for HIV infection.

Authors:  Douglas D Richman; David M Margolis; Martin Delaney; Warner C Greene; Daria Hazuda; Roger J Pomerantz
Journal:  Science       Date:  2009-03-06       Impact factor: 47.728

3.  Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells.

Authors:  Benjamin Descours; Veronique Avettand-Fenoel; Catherine Blanc; Assia Samri; Adeline Mélard; Virginie Supervie; Ioannis Theodorou; Guislaine Carcelain; Christine Rouzioux; Brigitte Autran
Journal:  Clin Infect Dis       Date:  2012-03-22       Impact factor: 9.079

4.  T cell Activation does not drive CD4 decline in longitudinally followed HIV-infected Elite Controllers.

Authors:  Philomena Kamya; Christos M Tsoukas; Salix Boulet; Jean-Pierre Routy; Réjean Thomas; Pierre Côté; Mohamed-Rachid Boulassel; Bernard Lessard; Rupert Kaul; Mario Ostrowski; Colin Kovacs; Cecile L Tremblay; Nicole F Bernard
Journal:  AIDS Res Ther       Date:  2011-06-16       Impact factor: 2.250

5.  Higher levels of HIV DNA in memory and naive CD4(+) T cell subsets of viremic compared to non-viremic patients after 18 and 24 months of HAART.

Authors:  F Baldanti; S Paolucci; R Gulminetti; R Maserati; G Migliorino; A Pan; F Maggiolo; G Comolli; A Chiesa; G Gerna
Journal:  Antiviral Res       Date:  2001-06       Impact factor: 5.970

6.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells.

Authors:  Michael R Betts; Martha C Nason; Sadie M West; Stephen C De Rosa; Stephen A Migueles; Jonathan Abraham; Michael M Lederman; Jose M Benito; Paul A Goepfert; Mark Connors; Mario Roederer; Richard A Koup
Journal:  Blood       Date:  2006-02-07       Impact factor: 22.113

7.  HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype.

Authors:  Asier Sáez-Cirión; Christine Lacabaratz; Olivier Lambotte; Pierre Versmisse; Alejandra Urrutia; Faroudy Boufassa; Françoise Barré-Sinoussi; Jean-François Delfraissy; Martine Sinet; Gianfranco Pancino; Alain Venet
Journal:  Proc Natl Acad Sci U S A       Date:  2007-04-11       Impact factor: 11.205

8.  HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation.

Authors:  Nicolas Chomont; Mohamed El-Far; Petronela Ancuta; Lydie Trautmann; Francesco A Procopio; Bader Yassine-Diab; Geneviève Boucher; Mohamed-Rachid Boulassel; Georges Ghattas; Jason M Brenchley; Timothy W Schacker; Brenna J Hill; Daniel C Douek; Jean-Pierre Routy; Elias K Haddad; Rafick-Pierre Sékaly
Journal:  Nat Med       Date:  2009-06-21       Impact factor: 53.440

9.  TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection.

Authors:  Huabiao Chen; Zaza M Ndhlovu; Dongfang Liu; Lindsay C Porter; Justin W Fang; Sam Darko; Mark A Brockman; Toshiyuki Miura; Zabrina L Brumme; Arne Schneidewind; Alicja Piechocka-Trocha; Kevin T Cesa; Jennifer Sela; Thai D Cung; Ildiko Toth; Florencia Pereyra; Xu G Yu; Daniel C Douek; Daniel E Kaufmann; Todd M Allen; Bruce D Walker
Journal:  Nat Immunol       Date:  2012-06-10       Impact factor: 25.606

10.  Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover.

Authors:  Jorge R Almeida; David A Price; Laura Papagno; Zaïna Aït Arkoub; Delphine Sauce; Ethan Bornstein; Tedi E Asher; Assia Samri; Aurélie Schnuriger; Ioannis Theodorou; Dominique Costagliola; Christine Rouzioux; Henri Agut; Anne-Geneviève Marcelin; Daniel Douek; Brigitte Autran; Victor Appay
Journal:  J Exp Med       Date:  2007-09-24       Impact factor: 14.307

View more
  15 in total

1.  BCL-2 antagonism sensitizes cytotoxic T cell-resistant HIV reservoirs to elimination ex vivo.

Authors:  Yanqin Ren; Szu Han Huang; Shabnum Patel; Winiffer D Conce Alberto; Dean Magat; Dughan Ahimovic; Amanda B Macedo; Ryan Durga; Dora Chan; Elizabeth Zale; Talia M Mota; Ronald Truong; Thomas Rohwetter; Chase D McCann; Colin M Kovacs; Erika Benko; Avery Wimpelberg; Christopher Cannon; W David Hardy; Alberto Bosque; Catherine M Bollard; R Brad Jones
Journal:  J Clin Invest       Date:  2020-05-01       Impact factor: 14.808

2.  Pharmacologic HIV-1 Nef blockade promotes CD8 T cell-mediated elimination of latently HIV-1-infected cells in vitro.

Authors:  Shariq Mujib; Aamir Saiyed; Saleh Fadel; Ardalan Bozorgzad; Nasra Aidarus; Feng Yun Yue; Erika Benko; Colin Kovacs; Lori A Emert-Sedlak; Thomas E Smithgall; Mario A Ostrowski
Journal:  JCI Insight       Date:  2017-09-07

3.  HIV-Specific Granzyme B-Secreting but Not Gamma Interferon-Secreting T Cells Are Associated with Reduced Viral Reservoirs in Early HIV Infection.

Authors:  Feng Yun Yue; Jared C Cohen; Mu Ho; A K M Nur-Ur Rahman; Jun Liu; Shariq Mujib; Aamir Saiyed; Sabrina Hundal; Alexandra Khozin; Phil Bonner; Daheng Liu; Erika Benko; Colin Kovacs; Mario Ostrowski
Journal:  J Virol       Date:  2017-03-29       Impact factor: 5.103

4.  Signatures of immune selection in intact and defective proviruses distinguish HIV-1 elite controllers.

Authors:  Xiaodong Lian; Ce Gao; Xiaoming Sun; Chenyang Jiang; Kevin B Einkauf; Kyra W Seiger; Joshua M Chevalier; Yuko Yuki; Maureen Martin; Rebecca Hoh; Michael J Peluso; Mary Carrington; Ezequiel Ruiz-Mateos; Steven G Deeks; Eric S Rosenberg; Bruce D Walker; Mathias Lichterfeld; Xu G Yu
Journal:  Sci Transl Med       Date:  2021-12-15       Impact factor: 19.319

5.  Short-Course Toll-Like Receptor 9 Agonist Treatment Impacts Innate Immunity and Plasma Viremia in Individuals With Human Immunodeficiency Virus Infection.

Authors:  Line Vibholm; Mariane H Schleimann; Jesper F Højen; Thomas Benfield; Rasmus Offersen; Katrine Rasmussen; Rikke Olesen; Anders Dige; Jørgen Agnholt; Judith Grau; Maria Buzon; Burghardt Wittig; Mathias Lichterfeld; Andreas Munk Petersen; Xutao Deng; Mohamed Abdel-Mohsen; Satish K Pillai; Sofie Rutsaert; Wim Trypsteen; Ward De Spiegelaere; Linos Vandekerchove; Lars Østergaard; Thomas A Rasmussen; Paul W Denton; Martin Tolstrup; Ole S Søgaard
Journal:  Clin Infect Dis       Date:  2017-06-15       Impact factor: 9.079

6.  HIV-1 latency and virus production from unintegrated genomes following direct infection of resting CD4 T cells.

Authors:  Chi N Chan; Benjamin Trinité; Caroline S Lee; Saurabh Mahajan; Akanksha Anand; Dominik Wodarz; Steffanie Sabbaj; Anju Bansal; Paul A Goepfert; David N Levy
Journal:  Retrovirology       Date:  2016-01-05       Impact factor: 4.602

Review 7.  Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction.

Authors:  Hongbing Yang; Zoë Wallace; Lucy Dorrell
Journal:  Front Immunol       Date:  2018-12-04       Impact factor: 7.561

8.  Have Cells Harboring the HIV Reservoir Been Immunoedited?

Authors:  Szu-Han Huang; Chase D McCann; Talia M Mota; Chao Wang; Steven M Lipkin; R Brad Jones
Journal:  Front Immunol       Date:  2019-08-06       Impact factor: 7.561

9.  Noncytolytic CD8+ Cell Mediated Antiviral Response Represents a Strong Element in the Immune Response of Simian Immunodeficiency Virus-Infected Long-Term Non-Progressing Rhesus Macaques.

Authors:  Aneela Javed; Nicole Leuchte; Berit Neumann; Sieghart Sopper; Ulrike Sauermann
Journal:  PLoS One       Date:  2015-11-09       Impact factor: 3.240

10.  Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells.

Authors:  Julie Boucau; Jishnu Das; Neelambari Joshi; Sylvie Le Gall
Journal:  PLoS Pathog       Date:  2020-03-20       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.